1. | | Completed | 3TC (Lamivudine; GR109714X) Open-Label Program Condition: HIV Infections |
2. | | Completed | The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-dideoxyinosine or 2',3'-dideoxycytidine in Patients with Human Immunodeficiency Virus Disease Condition: HIV Infections |
3. | | Completed | A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine Condition: HIV Infections |
4. | | Completed | A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients Conditions: Herpes Simplex; HIV Infections |
5. | | Completed | A Comparison of 141W94 and Indinavir in HIV-Infected Patients Condition: HIV Infections |
6. | | Completed | Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex Conditions: AIDS Dementia Complex; HIV Infections |
7. | | Completed | A Comparison of 882C87 Versus Acyclovir in the Treatment of Herpes Zoster in Patients with Weakened Immune Systems Conditions: HIV Infections; Chickenpox |
8. | | Completed | A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMX Conditions: Pneumonia, Pneumocystis carinii; HIV Infections |
9. | | Completed | Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients Conditions: HIV Infections; Chickenpox |
10. | | No longer recruiting | Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy Condition: HIV Infections |
11. | | No longer recruiting | Comparison of GW433908/Ritonavir to Nelfinavir When Used with Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs Condition: HIV Infections |
12. | | Completed | A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past Condition: HIV Infections |
13. | | Completed | Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients with No Symptoms of the Disease Condition: HIV Infections |
14. | | Completed | A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients Condition: HIV Infections |
15. | | Completed | A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the Past Condition: HIV Infections |
16. | | Completed | A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment Condition: HIV Infections |
17. | | Completed | A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination with Zidovudine in HIV-1 Infected Children Condition: HIV Infections |
18. | | Completed | CSP #428 - Treatment of Seizures in the Elderly Population Condition: seizures in the elderly |
19. | | Completed | A Dose-Frequency Trial of Oral Retrovir in Patients With AIDS or Severe ARC Condition: HIV Infections |
20. | | Completed | The Effect of Teaching HIV-Infected Patients about HIV and Treatment Condition: HIV Infections |
21. | | Completed | The Effect of Valacyclovir on the Detection of HIV from Genital Herpes Lesions in HIV-Infected Patients Conditions: Herpes Simplex; HIV Infections |
22. | | No longer recruiting | Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment Condition: HIV Infections |
23. | | Recruiting | Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected with HIV Condition: HIV Infections |
24. | | Completed | The Effects of Anti-HIV Drugs in HIV-Infected Patients Who Do Not Have AIDS Condition: HIV Infections |
25. | | Completed | The Effects of Zidovudine on the Blood of HIV-Infected Patients Condition: HIV Infections |
26. | | Completed | The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III) Conditions: Lymphatic Disease; HIV Infections |
27. | | Completed | Evaluation of Patients Who Have Not Had Success with Zidovudine Condition: HIV Infections |
28. | | No longer recruiting | Four-Drug Combination Therapy with Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients Condition: HIV Infections |
29. | | Completed | Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis carinii Pneumonia Prophylaxis Conditions: Pneumonia, Pneumocystis carinii; HIV Infections |
30. | | Completed | Methadone Effects on Zidovudine (ZDV, AZT) Disposition Condition: HIV Infections |
31. | | Completed | A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection Condition: HIV Infections |
32. | | Completed | An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects with HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen Condition: HIV Infections |
33. | | Completed | An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients with Severe PCP Who Are Intolerant and/or Unresponsive to Therapy with Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine Conditions: Pneumonia, Pneumocystis carinii; HIV Infections |
34. | | Completed | An Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2 Condition: HIV Infections |
35. | | Completed | A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI) Condition: HIV Infections |
36. | | Completed | A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC Condition: HIV Infections |
37. | | Completed | A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV) Condition: HIV Infections |
38. | | Completed | A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients with HIV Infection Condition: HIV Infections |
39. | | Completed | A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons Condition: HIV Infections |
40. | | Completed | A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3 Condition: HIV Infections |
41. | | Completed | A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease Condition: HIV Infections |
42. | | Completed | A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV Condition: HIV Infections |
43. | | Completed | A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis carinii Pneumonia in AIDS Patients Who are Intolerant of Trimethoprim / Sulfamethoxazole Conditions: Pneumonia, Pneumocystis carinii; HIV Infections |
44. | | Completed | A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDS Conditions: Pneumonia, Pneumocystis carinii; HIV Infections |
45. | | Completed | A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects. Condition: HIV Infections |
46. | | Completed | A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection Condition: HIV Infections |
47. | | Completed | A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex Conditions: AIDS Dementia Complex; HIV Infections |
48. | | Completed | A Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cells/mm3 Condition: HIV Infections |
49. | | Completed | A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or are Intolerant of Pyrimethamine-Sulfadiazine Conditions: Toxoplasmosis, Cerebral; HIV Infections |
50. | | Completed | A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS Conditions: Toxoplasmosis, Cerebral; HIV Infections |